INDUSTRY INSIGHTS

NEWS | PEOPLE | INNOVATIONS | TREATMENTS | UPDATES

What Happens When a MedSpa Closes? Protecting Client Packages, Gift Cards, and Building Trust

What Happens When a MedSpa Closes? Protecting Client Packages, Gift Cards, and Building Trust

Recently, I was talking with Natasha Sherrill, owner of New Age Medspa in Anchorage, Alaska, and she was telling me a story that reminded me why this industry (and the people who have built it) can be so incredible. A few months back, a pretty successful medspa in Anchorage closed abruptly, leaving clients with unused packages and gift cards. Instead of letting those clients suffer, local businesses (not just medspas) decided to honor the lost credits these clients held. They weren’t legally...

read more
GLP-1 Dispensing in Medspas: Complete Regulatory Guide for Semaglutide Administration vs. Dispensing

GLP-1 Dispensing in Medspas: Complete Regulatory Guide for Semaglutide Administration vs. Dispensing

Understanding the Critical Difference Between Administering and Dispensing GLP-1s in Your Medspa If you’ve been asked about dispensing certificates, physician dispensing licenses, or whether your medspa can send patients home with GLP-1 medications like Semaglutide, you’re facing one of the most complex regulatory challenges in aesthetic medicine today. This guide breaks down everything you need to know about legally offering GLP-1 therapies in your practice. The Two Pathways: Which One Is...

read more
Why Kyle Scheele’s “Crazy Ideas” Are Set to Inspire at AmSpa 2025

Why Kyle Scheele’s “Crazy Ideas” Are Set to Inspire at AmSpa 2025

Kyle Scheele isn’t your typical medspa conference speaker—and that’s exactly why his keynote matters. Find out how his entrepreneurial approach challenges the clinical thinking that holds most medspa owners back, and why his “just try it” philosophy might be the wake-up call the aesthetics industry desperately needs.

Breaking News: Evolus Prepares for Evolysse™ Launch with FDA Approval

Evolus is preparing for the official launch of Evolysse™, a new line of dermal fillers expected to rival Restylane® and Juvéderm®. With FDA approval pending for Q2 2025, medspa providers can now join Evolus’ early access list. Discover how Evolysse™ stands out with longer-lasting effects and advanced formulation technology.

read more

Whitney Ray Di Bona Calls CoolSculpting ‘The Biggest Sham’ in the Medspa Industry

Whitney Ray Di Bona, a renowned beauty lawyer, called out CoolSculpting as the biggest sham in the medspa industry during her recent interview on Culture Apothecary. From hidden risks like paradoxical adipose hyperplasia (PAH) to concerns about RF microneedling causing facial fat loss, her revelations offer medspa owners serious food for thought. This isn’t just gossip

read more

Stay Informed with The MedSpa Mastery Report

Sign up to get industry news, growth strategies, and exclusive offers delivered to your inbox